Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,862 | -13,532 | -60,822 | -52,441 | -36,071 |
| Depreciation Amortization | 2,850 | 398 | 1,634 | 1,234 | 832 |
| Accounts payable and accrued liabilities | N/A | N/A | -7,498 | N/A | N/A |
| Other Working Capital | -1,046 | 1,469 | -8,205 | -5,018 | -3,873 |
| Other Operating Activity | 4,090 | 1,068 | 14,599 | 6,957 | 5,000 |
| Operating Cash Flow | $-3,968 | $-10,597 | $-60,292 | $-49,268 | $-34,112 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 416 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $416 | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1 | N/A | 6,028 | 3,662 | 388 |
| Other Financing Activity | -32,413 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-32,412 | $N/A | $6,028 | $3,662 | $388 |
| Beginning Cash Position | 57,951 | 57,951 | 112,215 | 112,215 | 112,215 |
| End Cash Position | 21,987 | 47,354 | 57,951 | 66,609 | 78,491 |
| Net Cash Flow | $-35,964 | $-10,597 | $-54,264 | $-45,606 | $-33,724 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,968 | -10,597 | -60,292 | -49,268 | -34,112 |
| Free Cash Flow | -3,968 | -10,597 | -60,292 | -49,268 | -34,112 |